+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cardiac Insufficiency Drug"

From
Cardiac Insufficiency - Epidemiology Forecast - 2032 - Product Thumbnail Image

Cardiac Insufficiency - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
  • 2 Results (Page 1 of 1)
Loading Indicator

The Cardiac Insufficiency Drug market is a subset of the Cardiovascular Drugs market, which includes drugs used to treat heart conditions. Cardiac Insufficiency Drugs are used to treat heart failure, a condition in which the heart is unable to pump enough blood to meet the body's needs. These drugs work by improving the heart's ability to pump blood, reducing the workload on the heart, and improving the body's ability to use oxygen. Commonly used Cardiac Insufficiency Drugs include ACE inhibitors, beta blockers, diuretics, and angiotensin receptor blockers. The Cardiac Insufficiency Drug market is highly competitive, with many companies offering a variety of drugs to treat heart failure. Some of the major players in the market include Pfizer, Novartis, Merck, Sanofi, and Bristol-Myers Squibb. Show Less Read more